• Rheumatoid arthritis (NHS Choices)

• Rheumatoid arthritis (CKS)

• Rheumatoid arthritis and Still's disease (PCDS)

• Rheumatoid arthritis (Lancet series)

Systemic inflammatory mediators, endothelial dysfunction, and alteration of lipid metabolism contribute to excess cardiovascular disease in rheumatoid arthritis. Although steroids may reduce inflammation, they appear to be associated with increased cardiovascular disease, even at low doses.

Resource:

Pujades-Rodriguez M, Morgan A, Cubbon R. et al. Dose-dependent oral glucocorticoid cardiovascular risks in people with immune-mediated inflammatory diseases: A population-based cohort study. PLoSMed 2022; 17(12): e1003432.